Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
3200 participants
INTERVENTIONAL
2025-06-18
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The research team plans to enroll 3200 patients in this study. However, randomization may end due to system constraints on December 31, 2025 before reaching that target. This sample provides 80% power to detect a 35% relative reduction in ED utilization using a two-tailed test with an alpha of .15, assuming 40% compliance with the program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of Telehealth Mindfulness for Back Pain in the Emergency Department
NCT04783532
Cooperative Pain Education and Self-management
NCT02724930
Effectiveness of Home-Based Health Messaging for Patients With Hypertension and Diabetes
NCT00119054
Telemedicine Enabling Patients in Self-care Behaviors
NCT04297735
Exploratory Study Providing Telepsychiatry in the Home With a Clinician Present
NCT03854045
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Telemedicine Program
Patients will be invited to participate in the integrated telemedicine program through text, email, and/or phone calls.
Integrated Telemedicine Program
The integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker \[LCSW\]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider.
Control
Patients will receive only standard care and will receive no invitation to participate in the integrated telemedicine program.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrated Telemedicine Program
The integrated telemedicine program is short-term bridge support provided by a virtually accessible team, including a behavioral health provider (Health Psychologist or Licensed Clinical Social Worker \[LCSW\]) and Community Health Worker (CHW). Once stabilized, members transition from bridge support to ongoing care with a Geisinger Health System Primary Care Provider and Behavioral Health Provider.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 4+ Geisinger ED visits in the last 6 months
* Geisinger Health Plan (GHP) insurance member
* Has a Geisinger PCP
* Patient is being seen at one of the following facilities: Geisinger Lewistown Hospital, Geisinger Medical Center, Geisinger Bloomsburg Hospital, Geisinger Jersey Shore Hospital, Geisinger Community Medical Hospital, Geisinger Wyoming Valley, Geisinger Medical Center Muncy, Geisinger Shamokin Ach Hospital, Geisinger South Wilkes Barre
Exclusion Criteria
* Patient is diagnosed with alcohol and substance-related disorders
* Patient is going to receive inpatient care
* Patient is coded in the ED as Level 1 (i.e., seeking life-saving measures)
* Patient has an Intellectual Disability or Traumatic Brain Injury
* Patient is actively seeing a BH provider
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amir Goren
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geisinger Clinic
Danville, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-0554
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.